Header Logo

Connection

THOMAS MONATH to Adolescent

Back to Details
This is a "connection" page, showing publications THOMAS MONATH has written about Adolescent.
THOMAS MONATH
Connection Strength
0.382
Adolescent
  1. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J Clin Invest. 2022 05 16; 132(10).
    View in: PubMed
    Score: 0.055
  2. Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic. Vaccine. 2017 08 16; 35(35 Pt A):4465-4469.
    View in: PubMed
    Score: 0.039
  3. Yellow fever vaccine seroconversion in travelers. Am J Trop Med Hyg. 2011 Oct; 85(4):748-9.
    View in: PubMed
    Score: 0.026
  4. An inactivated cell-culture vaccine against yellow fever. N Engl J Med. 2011 Apr 07; 364(14):1326-33.
    View in: PubMed
    Score: 0.026
  5. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. Vaccine. 2009 Mar 04; 27(10):1637-44.
    View in: PubMed
    Score: 0.022
  6. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A. 2006 Apr 25; 103(17):6694-9.
    View in: PubMed
    Score: 0.018
  7. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum Vaccin. 2006 Mar-Apr; 2(2):60-7.
    View in: PubMed
    Score: 0.018
  8. Yellow fever 17D vaccine safety and immunogenicity in the elderly. Hum Vaccin. 2005 Sep-Oct; 1(5):207-14.
    View in: PubMed
    Score: 0.017
  9. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine. 2005 May 09; 23(25):3301-9.
    View in: PubMed
    Score: 0.017
  10. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
    View in: PubMed
    Score: 0.016
  11. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil. Microbiol Spectr. 2024 May 02; 12(5):e0370323.
    View in: PubMed
    Score: 0.016
  12. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep. 2002 Nov 08; 51(RR-17):1-11; quiz CE1-4.
    View in: PubMed
    Score: 0.014
  13. Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun. 2001 Feb; 69(2):988-95.
    View in: PubMed
    Score: 0.013
  14. Early indicators in acute dengue infection. Lancet. 1997 Dec 13; 350(9093):1719-20.
    View in: PubMed
    Score: 0.010
  15. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. CMAJ. 2017 Jun 19; 189(24):E819-E827.
    View in: PubMed
    Score: 0.010
  16. Safety and immunogenicity of the rVSV?G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet Infect Dis. 2017 08; 17(8):854-866.
    View in: PubMed
    Score: 0.010
  17. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg. 1993 Feb; 48(2):274-99.
    View in: PubMed
    Score: 0.007
  18. Detection of yellow fever viral RNA by nucleic acid hybridization and viral antigen by immunocytochemistry in fixed human liver. Am J Trop Med Hyg. 1989 Jun; 40(6):663-8.
    View in: PubMed
    Score: 0.006
  19. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol. 2003 Nov; 98(11):2395-402.
    View in: PubMed
    Score: 0.004
  20. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis. 2003 Nov 01; 188(9):1263-75.
    View in: PubMed
    Score: 0.004
  21. Posttreatment follow-up of Helicobacter pylori infection using a stool antigen immunoassay. Clin Diagn Lab Immunol. 2001 Jul; 8(4):718-23.
    View in: PubMed
    Score: 0.003
  22. Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg. 1980 Sep; 29(5):912-28.
    View in: PubMed
    Score: 0.003
  23. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas. Am J Trop Med Hyg. 1980 Jul; 29(4):624-34.
    View in: PubMed
    Score: 0.003
  24. Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico. Am J Trop Med Hyg. 1999 Apr; 60(4):587-92.
    View in: PubMed
    Score: 0.003
  25. St. Louis encephalitis in Memphis-Shelby County, Tennessee, 1975: epidemiologic aspects of human cases. South Med J. 1978 Jun; 71(6):633-7.
    View in: PubMed
    Score: 0.003
  26. Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ. 1975; 52(4-6):577-92.
    View in: PubMed
    Score: 0.002
  27. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg. 1974 Nov; 23(6):1140-9.
    View in: PubMed
    Score: 0.002
  28. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg. 1993 May-Jun; 87(3):337-9.
    View in: PubMed
    Score: 0.002
  29. The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. I. Epidemiological observations. Bull World Health Organ. 1973; 49(2):113-21.
    View in: PubMed
    Score: 0.002
  30. The 1970 yellow fever epidemic in Okwoga District Benue Plateau State, Nigeria. 2. Immunity survey to determine geographic limits and origins of the epidemic. Bull World Health Organ. 1973; 49(2):123-8.
    View in: PubMed
    Score: 0.002
  31. The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity. Bull World Health Organ. 1973; 49(3):235-44.
    View in: PubMed
    Score: 0.002
  32. Studies on California encephalitis in Minnesota. Am J Epidemiol. 1970 Jul; 92(1):40-50.
    View in: PubMed
    Score: 0.002
  33. Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg. 1989 May-Jun; 83(3):401-6.
    View in: PubMed
    Score: 0.001
  34. Human immunodeficiency virus infection in a rural community. J Fla Med Assoc. 1988 May; 75(5):301-4.
    View in: PubMed
    Score: 0.001
  35. Epidemic yellow fever in eastern Nigeria, 1986. Lancet. 1988 Mar 19; 1(8586):630-3.
    View in: PubMed
    Score: 0.001
  36. Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Prog Clin Biol Res. 1983; 123:31-41.
    View in: PubMed
    Score: 0.001
  37. Human arboviral infections in the United States in 1980. J Infect Dis. 1982 Feb; 145(2):283-6.
    View in: PubMed
    Score: 0.001
  38. Epidemiologic investigations of the 1969 epidemic of Venezuelan encephalitis in Ecuador. Am J Epidemiol. 1975 Nov; 102(5):400-13.
    View in: PubMed
    Score: 0.001
  39. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg. 1974 Nov; 23(6):1131-9.
    View in: PubMed
    Score: 0.001
  40. Bwamba virus infection: a sero-survey of veterbrates in five ecological zones in Nigeria. Trans R Soc Trop Med Hyg. 1974; 68(6):461-5.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.